<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00200707</url>
  </required_header>
  <id_info>
    <org_study_id>BRD/03/2-B</org_study_id>
    <nct_id>NCT00200707</nct_id>
  </id_info>
  <brief_title>BONAMI (BOne Marrow in Acute Myocardial Infarction)</brief_title>
  <official_title>Intracoronary Injection of Autologous Bone Marrow Mononuclear Cells for Severe Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Emerging evidence suggests that stem cells and progenitor cells derived from bone marrow can
      be used to improve cardiac function in patients after acute myocardial infarction. In this
      randomised trial, we aim to assess whether intracoronary transfer of autologous bone-marrow
      cells could improve myocardial viability at 3 and 12 months' follow-up.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After successful percutaneous coronary intervention (PCI) for acute myocardial infarction,
      100 patients are randomly assigned to either a control group (n=50) who receives an optimal
      medical treatment, or a bone-marrow-cell group (n=50) who receives an optimal medical
      treatment and intracoronary transfer of autologous bone-marrow cells 7â€¢10 days after PCI.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2004</start_date>
  <completion_date type="Actual">April 2009</completion_date>
  <primary_completion_date type="Actual">January 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Myocardial viability evaluated by thallium scintigraphy (3 months and 1 year)</measure>
    <time_frame>after 3 months and 1 year of treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Left ventricle ejection fraction (LVEF) evaluated by radionuclide ventriculography, (3 and 12 months) and by echography (1, 3, 6, and 12 months). Segmental EF and myocardial viability evaluated by MRI (3 months)</measure>
    <time_frame>after 1,3,6 ,12 months of treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation with biological parameters (hematopoietic stem cell number, etc.) at the time of cell injection</measure>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">101</enrollment>
  <condition>Acute and Severe Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>The treatment group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intracoronary Injection of Autologous Bone Marrow Mononuclear C</description>
  </arm_group>
  <arm_group>
    <arm_group_label>the control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intracoronary injection of autologous bone marrow mononuclear cells</intervention_name>
    <arm_group_label>The treatment group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men or women between 18-75 years.

          -  Acute myocardial infarction

          -  Absence of viability in the infarcted zone and LVEF &lt;45%.

        Exclusion Criteria:

          -  History of prior myocardial infarction

          -  Significant stenosis in another coronary territory than the acutely treated vessel
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patricia LEMARCHAND, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nantes University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2005</study_first_posted>
  <last_update_submitted>April 29, 2014</last_update_submitted>
  <last_update_submitted_qc>April 29, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 30, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cell therapy</keyword>
  <keyword>bone marrow mononuclear cells</keyword>
  <keyword>myocardial infarction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

